Slusarczyk; Magdalena

Patent Applications and Registrations

Patent applications and USPTO patent grants for Slusarczyk; Magdalena.The latest application filed is for "salt of triphosphate phosphoramidates of nucleotides as anticancer compounds".

Company Profile

5.8.12

Slusarczyk; Magdalena - Cardiff GB
Slusarczyk; Magdalena - Cardiff South Glamorgan GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Salt Of Triphosphate Phosphoramidates Of Nucleotides As Anticancer Compounds App 20220024963 - Griffith; Hugh ; et al.	2022-01-27
Phosphoramidate Derivatives Of 5 - Fluoro - 2` - Deoxyuridine For Use In The Treatment Of Cancer App 20220023330 - McGuigan; Christopher ; et al.	2022-01-27
Salts Of Diphosphate Phosphoramidate Of Nucleosides As Anticancer Compounds App 20210171566 - Griffith; Hugh ; et al.	2021-06-10
Phosphoramidate Nucleoside Derivatives As Anticancer Agents App 20210130387 - Griffith; Hugh ; et al.	2021-05-06
Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer Grant 10,993,957 - McGuigan , et al. May 4, 2	2021-05-04
Phosphoramidate nucleoside derivatives as anticancer agents Grant 10,906,929 - Griffith , et al. February 2, 2	2021-02-02
Gemcitabine Prodrugs App 20200262861 - Griffith; Hugh ; et al.	2020-08-20
Gemcitabine prodrugs Grant 10,662,213 - Griffith , et al.	2020-05-26
Phosphoramidate Derivatives Of 5 - Fluoro - 2` - Deoxyuridine For Use In The Treatment Of Cancer App 20190201432 - McGuigan; Christopher ; et al.	2019-07-04
Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer Grant 10,022,390 - McGuigan , et al. July 17, 2	2018-07-17
Phosphoramidate Derivatives Of 5 - Fluoro - 2` - Deoxyuridine For Use In The Treatment Of Cancer App 20170312302 - McGuigan; Christopher ; et al.	2017-11-02
Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer Grant 9,655,915 - McGuigan , et al. May 23, 2	2017-05-23
Gemcitabine Prodrugs App 20170107246 - Griffith; Hugh ; et al.	2017-04-20
Phosphoramidate Derivatives Of 5 - Fluoro - 2` - Deoxyuridine For Use In The Treatment Of Cancer App 20160166596 - McGuigan; Christopher ; et al.	2016-06-16
Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer Grant 9,221,866 - McGuigan , et al. December 29, 2	2015-12-29
Phosphoramidate Derivatives Of 5-fluoro-2'-deoxyuridine For Use In The Treatment Of Cancer App 20150183817 - McGuigan; Christopher ; et al.	2015-07-02
Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer Grant 8,933,053 - McGuigan , et al. January 13, 2	2015-01-13
Phosphoramidate Derivatives Of 5 - Fluoro - 2` - Deoxyuridine For Use In The Treatment Of Cancer App 20140057866 - McGuigan; Christopher ; et al.	2014-02-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.